We are live on
!
Find out more
O
OrbiMed Portfolio holdings
AUM
$4.59B
1-Year Est. Return
125.28%
This Fund
S&P 500
This Quarter
Est. Return
+7.88%
1 Year Est. Return
+125.28%
3 Year Est. Return
+334.72%
5 Year Est. Return
+344.07%
10 Year Est. Return
+2,748.76%
AUM
$3.98B
AUM Growth
-$187M
(-4.5%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-5.94%
Top 10 Holdings %
Top 10 Hldgs %
49.18%
Holding
122
New
13
Increased
19
Reduced
24
Closed
22
Top Buys
| 1 |
CAI
Caris Life Sciences
CAI
|
+$81.8M |
| 2 |
UnitedHealth
UNH
|
+$51.6M |
| 3 |
Roivant Sciences
ROIV
|
+$30.1M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$23.2M |
| 5 |
JBIO
Jade Biosciences
JBIO
|
+$18.1M |
Top Sells
| 1 |
Pfizer
PFE
|
+$97.6M |
| 2 |
Ionis Pharmaceuticals
IONS
|
+$76.6M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$56.9M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
+$41.9M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$34.5M |
Sector Composition
| 1 | Healthcare | 99.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SVA
1
DELISTED
Sinovac Biotech, Ltd
SVA
| $334M | 8.4% |
2,718,735
| – | – |
|
2
Boston Scientific
BSX
$64.4B
| $302M | 7.6% |
2,813,200
| – | – |
|
3
Eli Lilly
LLY
$1.02T
| $263M | 6.62% |
337,600
| – | – |
|
4
Edgewise Therapeutics
EWTX
$4.25B
| $203M | 5.12% |
15,518,492
+496,771
| +3% | +$7.16M |
|
5
Enliven Therapeutics
ELVN
$3.71B
| $160M | 4.02% |
7,959,538
| – | – |
|
6
Intuitive Surgical
ISRG
$138B
| $158M | 3.98% |
291,000
| – | – |
|
7
ARS Pharmaceuticals
SPRY
$749M
| $145M | 3.64% |
8,288,510
| – | – |
|
8
Stryker
SYK
$121B
| $142M | 3.57% |
359,200
| – | – |
|
9
Edwards Lifesciences
EW
$50.8B
| $134M | 3.36% |
1,708,000
+176,000
| +11% | +$13.1M |
|
10
argenx
ARGX
$54B
| $115M | 2.88% |
208,000
+1,300
| +0.6% | +$754K |
|
11
Alnylam Pharmaceuticals
ALNY
$37.6B
| $111M | 2.8% |
341,900
-4,200
| -1% | -$1.16M |
|
|
12
UnitedHealth
UNH
$382B
| $105M | 2.64% |
336,300
+135,100
| +67% | +$51.6M |
|
13
Natera
NTRA
$39.5B
| $100M | 2.52% |
593,434
+46,434
| +8% | +$7.24M |
|
|
14
Vertex Pharmaceuticals
VRTX
$120B
| $93.6M | 2.35% |
210,287
+50,387
| +32% | +$23.2M |
|
15
Tenet Healthcare
THC
$16.3B
| $81.8M | 2.06% |
465,000
| – | – |
|
|
CAI
16
Caris Life Sciences
CAI
$4.86B
| $81.1M | 2.04% |
+3,034,858
| New | +$81.8M |
|
17
Disc Medicine
IRON
$2.86B
| $74.9M | 1.88% |
1,415,020
| – | – |
|
18
ArriVent BioPharma
AVBP
$1.56B
| $65.9M | 1.66% |
3,027,328
| – | – |
|
|
SION
19
Sionna Therapeutics
SION
$1.94B
| $64.3M | 1.62% |
3,704,959
| – | – |
|
|
UPB
20
Upstream Bio Inc
UPB
$393M
| $62.5M | 1.57% |
5,693,589
| – | – |
|
|
21
Neurocrine Biosciences
NBIX
$17.3B
| $55.1M | 1.39% |
438,540
-496,100
| -53% | -$56.9M |
|
22
Integer Holdings
ITGR
$3.23B
| $53.3M | 1.34% |
433,400
-229,100
| -35% | -$27.4M |
|
|
RNAM
23
DELISTED
Avidity Biosciences
RNAM
| $51.5M | 1.29% |
1,812,886
| – | – |
|
24
CG Oncology
CGON
$6.53B
| $48.8M | 1.23% |
1,877,850
-594,144
| -24% | -$14.3M |
|
25
SI-BONE Inc
SIBN
$759M
| $48.5M | 1.22% |
2,578,979
-863,874
| -25% | -$14.3M |
|
Similar funds
CGI
LNWTC
SCM
AG
SCM
SV
ANTB
ECM